- Here’s that ‘SpaceX’s IPO is overvalued by 114%’ research in full Financial Times
- Wall Street’s undignified SpaceX mania The Economist
- A rebound with staying power may be in the cards for this beat-up medical devices ETF CNBC
- SpaceX IPO demand is approaching four times oversubscribed, source says Reuters
- Elon Musk Is About to Make Saving for Retirement Even Harder The American Prospect
Add Comment